Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis

Poveda, A; Lheureux, S; Colombo, N; Cibula, D; Lindemann, K; Weberpals, J; Bjurberg, M; Oaknin, A; Sikorska, M; Gonzalez-Martin, A; Madry, R; Perez, MJR; Ledermann, J; Davidson, R; Blakeley, C; Bennett, J; Barnicle, A; Skof, E

Poveda, A (通讯作者)，Initia Oncol, Hosp Quironsalud, Ave Blasco Ibanez 14, Valencia 46010, Spain.

GYNECOLOGIC ONCOLOGY, 2022; 164 (3): 498

Abstract

Objective. The phase IIIb OPINION trial (NCT03402841) investigated olaparib maintenance monotherapy in patients without a deleterious or suspected del......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索